Revised Suit Seeks Full OTC Status For Plan B One-Step And Generics
This article was originally published in The Tan Sheet
Executive Summary
The Center for Reproductive Rights amends its suit against FDA to compel universal OTC access to levonorgestrel emergency contraceptives. The advocacy group adds HHS Secretary Kathleen Sebelius as a defendant after her recent decision to overrule FDA’s approval of OTC sales for Plan B One-Step.